Aflibercept a new target therapy in cancer treatment: a review.
Crit Rev Oncol Hematol
; 96(3): 569-76, 2015 Dec.
Article
in En
| MEDLINE
| ID: mdl-26224565
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Recombinant Fusion Proteins
/
Receptors, Vascular Endothelial Growth Factor
/
Molecular Targeted Therapy
/
Neoplasms
/
Neovascularization, Pathologic
Type of study:
Prognostic_studies
Limits:
Humans
Language:
En
Journal:
Crit Rev Oncol Hematol
Journal subject:
HEMATOLOGIA
/
NEOPLASIAS
Year:
2015
Document type:
Article
Affiliation country:
Italy
Country of publication:
Netherlands